Overview
- From 2014 to 2024, U.S. pharmacies dispensed 1.6 billion inhalers that generated an estimated 24.9 million metric tons of CO2e.
- Metered‑dose inhalers using hydrofluoroalkane propellants produced about 98% of inhaler‑related emissions, far exceeding dry‑powder and soft‑mist devices.
- Annual emissions rose roughly 24% over the decade, increasing from about 1.9 million to 2.3 million metric tons.
- The Department of Veterans Affairs’ prioritization of dry‑powder devices since 2021 cut its inhaler emissions by more than 68% from 2008 to 2023.
- Study authors and an accompanying commentary call for payers and regulators to expand access to lower‑emission options and ensure forthcoming low‑GWP MDIs are affordable, noting insurance barriers and medical exceptions for some patients.